Stay updated on Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed Revision: v3.4.1 and the government funding status notice; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide funding-status notice was added and the page revision updated to v3.4.1, replacing the previous v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display to the page to clarify terms, and updated metadata to include the 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' entries, along with a revision note indicating v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 deployed replacing v3.3.3; no visible content changes observed with this update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section featuring Pennsylvania as a location, replacing the old Pennsylvania Locations header. Removed the HHS Vulnerability Disclosure footer link and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check91 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 in the release notes/footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.